Multicentre randomised controlled trial to evaluate the efficacy of pre-emptive inferior mesenteric artery embolisation during endovascular aortic aneurysm repair on …

S Ichihashi, M Takahara, N Fujimura, S Nagatomi… - BMJ open, 2020 - bmjopen.bmj.com
Introduction Type II endoleak (EL) is frequently seen after endovascular aneurysm repair
(EVAR) for abdominal aortic aneurysm (AAA) and is often considered responsible for …

Multicentre randomised controlled trial to evaluate the efficacy of pre-emptive inferior mesenteric artery embolisation during endovascular aortic aneurysm repair on …

S Ichihashi, M Takahara, N Fujimura, S Nagatomi… - BMJ Open, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Introduction</jats: title>< jats: p> Type II endoleak (EL) is
frequently seen after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm …

Multicentre randomised controlled trial to evaluate the efficacy of pre-emptive inferior mesenteric artery embolisation during endovascular aortic aneurysm repair on …

S Ichihashi, M Takahara, N Fujimura, S Nagatomi… - BMJ, 2020 - hero.epa.gov
Type II endoleak (EL) is frequently seen after endovascular aneurysm repair (EVAR) for
abdominal aortic aneurysm (AAA) and is often considered responsible for aneurysm sac …

[HTML][HTML] Multicentre randomised controlled trial to evaluate the efficacy of pre-emptive inferior mesenteric artery embolisation during endovascular aortic aneurysm …

S Ichihashi, M Takahara, N Fujimura, S Nagatomi… - BMJ Open, 2020 - ncbi.nlm.nih.gov
AbstrACt Introduction Type II endoleak (EL) is frequently seen after endovascular aneurysm
repair (EVAR) for abdominal aortic aneurysm (AAA) and is often considered responsible for …

[PDF][PDF] Shigeo Ichihashi, Mitsuyoshi Takahara, 2 Naoki Fujimura, 3 Satoru Nagatomi

S Iwakoshi, F Bolstad, K Kichikawa - academia.edu
AbstrACt Introduction Type II endoleak (EL) is frequently seen after endovascular aneurysm
repair (EVAR) for abdominal aortic aneurysm (AAA) and is often considered responsible for …

Multicentre randomised controlled trial to evaluate the efficacy of pre-emptive inferior mesenteric artery embolisation during endovascular aortic aneurysm repair on …

S Ichihashi, M Takahara, N Fujimura, S Nagatomi… - BMJ …, 2020 - search.proquest.com
Materials and methods The Standard Protocol Items: Recommendations for Interventional
Trials checklist has been used to report the trial's design, conduct, analysis and …

Multicentre randomised controlled trial to evaluate the efficacy of pre-emptive inferior mesenteric artery embolisation during endovascular aortic aneurysm repair on …

S Ichihashi, M Takahara, N Fujimura… - BMJ …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction Type II endoleak (EL) is frequently seen after endovascular aneurysm repair
(EVAR) for abdominal aortic aneurysm (AAA) and is often considered responsible for …

Multicentre randomised controlled trial to evaluate the efficacy of pre-emptive inferior mesenteric artery embolisation during endovascular aortic aneurysm repair on …

S Ichihashi, M Takahara, N Fujimura, S Nagatomi… - BMJ Open, 2020 - europepmc.org
Type II endoleak (EL) is frequently seen after endovascular aneurysm repair (EVAR) for
abdominal aortic aneurysm (AAA) and is often considered responsible for aneurysm sac …

Multicentre randomised controlled trial to evaluate the efficacy of pre-emptive inferior mesenteric artery embolisation during endovascular aortic aneurysm repair on …

S Ichihashi, M Takahara, N Fujimura, S Nagatomi… - BMJ …, 2020 - keio.elsevierpure.com
Abstract Introduction Type II endoleak (EL) is frequently seen after endovascular aneurysm
repair (EVAR) for abdominal aortic aneurysm (AAA) and is often considered responsible for …

[PDF][PDF] Shigeo Ichihashi, Mitsuyoshi Takahara, 2 Naoki Fujimura, 3 Satoru Nagatomi

S Iwakoshi, F Bolstad, K Kichikawa - researchmap.jp
AbstrACt Introduction Type II endoleak (EL) is frequently seen after endovascular aneurysm
repair (EVAR) for abdominal aortic aneurysm (AAA) and is often considered responsible for …